Abstract
We report the case of a 54-year-old female patient with stage IIIA kappa light chain myeloma (MM) who relapsed 7 years after syngeneic bone marrow transplantation (BMT). The relapse occurred as a voluminous soft tissue plasmacytoma in the leg, developing after local trauma. The patient was successfully treated with local radiotherapy and has remained progression-free for more than 2 years. This case represents one of the longest survivors, in complete remission, after syngeneic transplantation for MM. The presentation of recurrent disease as localized plasmacytoma with extramedullary growth is unusual in the post-transplant setting. Bone Marrow Transplantation (2000) 25, 115–117.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gregory WM, Richards MA, Malpas JS . Combination chemotherapy vs melphalan and prednisone in the treatment of multiple myeloma: an overview of published trials J Clin Oncol 1992 10: 334–342
Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91–97
Bensinger WI, Buckner CD, Gahrton G . Allogeneic stem cell transplantation for multiple myeloma Hematol/ Oncol Clin N Am 1997 11: 147–157
Topolsky D, Crilley P, Leasure N et al. Syngeneic marrow transplantation in multiple myeloma Leukemia Res 1992 16: 415–416
Wolff SN, McCurley TL, Giannone L . High-dose chemo-radiotherapy with syngeneic bone marrow transplantation formultiple myeloma: a case report and literature review Am JHematol 1987 26: 191–198
Bensinger WI, Demirer T, Buckner CD et al. Syngeneic marrow transplantation in patients with multiple myeloma Bone Marrow Transplant 1996 18: 527–531
Soeson M, Paccagnella A, Chiarion-Sileni V et al. Extramedullary plasmacytoma: clinical behaviour and response to treatment Ann Oncol 1992 3: 51–57
Moreau P, Bataille R, Mahé B et al. High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma J Clin Oncol 1993 11: 1832
Lokhorst HM, Meuwissen OJ, Verdonck LF et al. High-risk multiple myeloma treated with high-dose melphalan J Clin Oncol 1992 10: 47–51
Celsing F, Hast R, Stenke L et al. Extramedullary progression of multiple myeloma following GM-CSF treatment Eur J Haematol 1992 49: 108
Van Riet I, Bakkus M, De Greef C et al. Homing mechanisms in the etiopathogenesis of multiple myeloma Stem Cells 1995 13: (Suppl.2) 22–27
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trullemans, F., Schots, R., Storme, G. et al. Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation. Bone Marrow Transplant 25, 115–117 (2000). https://doi.org/10.1038/sj.bmt.1702092
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702092
Keywords
This article is cited by
-
Multiple myeloma of the thoracic spine developed at the previous trauma site: case report
European Spine Journal (2005)
-
Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission
Bone Marrow Transplantation (2003)
-
Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation
Bone Marrow Transplantation (2001)